13.11.2017
- Amid estimates that the business could be worth as much as $1.5 billion, speculation is mounting that Swiss drugmaker Novartis may be planning to sell its dermatology generics arm...
12.09.2016
- As it prepares to pay a higher price to acquire US agrochemicals giant Monsanto – if it comes to a deal at all – Bayer is said to be exploring the sale of its dermatology business...
07.07.2016
- British-Swedish drugmaker AstraZeneca has formed a strategic partnership with Denmark’s LEO Pharma for skin disease treatments. Under the deal, LEO gains a global license to...
19.05.2016
- Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...
04.01.2016
- Pershing Square Capital Management, the hedge fund of billionaire US activist investor Bill Ackman, has trimmed its stake in Canada-headquartered Valeant Pharmaceuticals from...
07.04.2015
- Belgium's UCB has agreed to sell its established brands in India, including its franchises in the areas of allergies and respiratory disorders, to Dr. Reddy's Laboratories for INR...
02.04.2013
- Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...
17.11.2012
- The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical, without conditions...
